Sema~Glutide
Sema~Glutide
Quantity
Minimum order is: 1 boxShipping
Supplier will ship within 2–10 days of confirmed payment.
Goods will be dispatched from United Kingdom port.
Shipping is offered under FOB terms — the supplier covers costs to the named port of shipment.
Payment: Western Union
Sample available · $200.00/sample
Euromart Suppliers order protection
Every payment you make is secured with strict SSL encryption and PCI DSS data protection protocols
Make free local returns for defects on qualifying purchases
Claim a refund if your order doesn't ship, is missing, or arrives with product issues
Meet your supplier
Distributor / Wholesaler • 3 yr • 
UNITED KINGDOM
56%
On-time delivery rate
≤24h
Response Time
75
Employee Size
$500K
Annual Revenue
588
Products Sold
Location
Belfast, United Kingdom
KEY FEATURES
Therapeutic Class: GLP‑1 receptor agonist (peptide therapy)
Primary Uses: Type 2 diabetes management, chronic weight management
Mechanism of Action :
Stimulates insulin secretion when glucose is elevated
Reduces glucagon release
Slows gastric emptying → appetite suppression
Clinical Benefits :
Proven HbA1c reduction
Average 10-15% weight loss during trial
Cardiovascular protection (reduced risk of heart attack/stroke in diabetic patients)
TECHNICAL SPECIFICATIONS
Molecular Type: Synthetic peptide (semaglutide)
Dosage forms :
Injection pens: 0.25 mg, 0.5 mg, 1 mg, 2 mg (weekly dosing)
Oral tablets: 3 mg, 7 mg, 14 mg (daily dosing)
Brands/Models:
Ozempic® – Weekly injection pen for type 2 diabetes
Wegovy® – Weekly injection pen for weight management
Rybelsus® – Daily oral tablet for type 2 diabetes
Storage & Handling :
Injection pens: Refrigerate until first use; room temperature up to 56 days after opening
Tablets: Store at room temperature, away from moisture
Safety profile :
Common side effects: Nausea, diarrhea, constipation
Serious risks: Pancreatitis, gallbladder issues, kidney problems, rare thyroid tumors
Contraindications: Type 1 diabetes, pregnancy, breastfeeding, history of medullary thyroid carcinoma or MEN2
AVAILABLE CONFIGURATIONS
Format and Delivery :
Prefilled injection pens (fixed strengths)
Oral tablets (daily dosing)
Compounded vials (for specialized clinical supply)
Concerntration & Dosing:
Branded pens: fixed strengths (0.25–2 mg)
Oral tablets: fixed strengths (3–14 mg)
Custom compounding: adjustable concentrations for research or clinical customization
Packaging & Lebeling:
Bulk API shipments
Finished product packaging (retail-ready)
Private labeling / white‑label options for distributors
Shipping and Compliance :
Cold chain logistics available
Flexible Incoterms (FOB, CIF, DAP, DDP)
Documentation tailored to HS code classification and regulatory requirements
GB
